Pulmonary hypertension: Work in progress

[1]  C. Wagenvoort,et al.  The pathology of pulmonary veno-occlusive disease , 2005, Virchows Archiv A.

[2]  R. Günther,et al.  Pulmonary embolism: comparison of angiography with spiral computed tomography, magnetic resonance angiography, and real-time magnetic resonance imaging. , 2003, American journal of respiratory and critical care medicine.

[3]  M. Sutton,et al.  Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. , 2003, American journal of respiratory and critical care medicine.

[4]  P. Thistlethwaite,et al.  Signaling molecules in nonfamilial pulmonary hypertension. , 2003, The New England journal of medicine.

[5]  G. Adam,et al.  MR-Bildgebung der Lungenventilation mittels aerosolierter Gadolinium-Chelate , 2003 .

[6]  olfgang,et al.  HEPARIN PLUS ALTEPLASE COMPARED WITH HEPARIN ALONE IN PATIENTS WITH SUBMASSIVE PULMONARY EMBOLISM , 2002 .

[7]  James A Scott.  Pulmonary perfusion patterns and pulmonary arterial pressure. , 2002, Radiology.

[8]  S. Rich,et al.  Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. , 2002, Chest.

[9]  K. Fukuchi,et al.  Quantitative analysis of lung perfusion in patients with primary pulmonary hypertension. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  M. Oudkerk,et al.  Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study , 2002, The Lancet.

[11]  R. Barst,et al.  Bosentan therapy for pulmonary arterial hypertension. , 2002, The New England journal of medicine.

[12]  S. Rich,et al.  Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.

[13]  R. Saouaf,et al.  Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  R. Mcevoy,et al.  Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. , 2002, American journal of respiratory and critical care medicine.

[15]  S. Eddahibi,et al.  Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis , 2001, Respiratory research.

[16]  B. Cairns,et al.  Inhaled Nitric Oxide for Primary Pulmonary Hypertension in Pregnancy , 2001, Obstetrics and gynecology.

[17]  F. Bellotto,et al.  Plasma markers of endothelial dysfunction in pulmonary hypertension. , 2001, Chest.

[18]  F. Saulnier,et al.  Aerosolized iloprost in CREST syndrome related pulmonary hypertension. , 2001, The Journal of rheumatology.

[19]  V. Peinado,et al.  Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. , 2001, American journal of respiratory and critical care medicine.

[20]  John Arul Phillips,et al.  Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. , 2001, The New England journal of medicine.

[21]  I. Susanto,et al.  Pulmonary artery systolic pressures estimated by echocardiogram vs cardiac catheterization in patients awaiting lung transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  A. Kokesova,et al.  Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels. , 2001, Journal of applied physiology.

[23]  L. Monnery,et al.  Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. , 2001, British journal of anaesthesia.

[24]  T. Garite,et al.  A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. , 2001, American journal of obstetrics and gynecology.

[25]  P. Nihoyannopoulos,et al.  Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. , 2001, The European respiratory journal.

[26]  F. Chang,et al.  Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations , 2001, Journal of Gastroenterology.

[27]  D. Launay,et al.  Dépistage de l'hypertension artérielle pulmonaire au cours de la sclérodermie systémique : étude d'une cohorte de 67 patients , 2000 .

[28]  H. Farber,et al.  Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. , 2000, American journal of respiratory and critical care medicine.

[29]  P. Friedman,et al.  Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. , 2000, American journal of respiratory and critical care medicine.

[30]  M. Humbert,et al.  Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family , 2000, Journal of medical genetics.

[31]  I. Khan,et al.  HIV-Related pulmonary hypertension: analytic review of 131 cases. , 2000, Chest.

[32]  S. Hodge,et al.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.

[33]  R. Pierson,et al.  Lung allocation in the United States, 1995-1997: an analysis of equity and utility. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  F. Sakamaki,et al.  Correlation between severity of pulmonary arterial hypertension and 123I-metaiodobenzylguanidine left ventricular imaging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  R. Wiesner,et al.  Pulmonary hemodynamics and perioperative cardiopulmonary‐related mortality in patients with portopulmonary hypertension undergoing liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  F. Sakamaki,et al.  Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension. , 2000, Circulation.

[37]  W. Seeger,et al.  Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial , 2000, Annals of Internal Medicine.

[38]  Stuart Rich,et al.  Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease , 2000, Annals of Internal Medicine.

[39]  Barst Rj.  Role of atrial septostomy in the treatment of pulmonary vascular disease , 2000 .

[40]  K. Thornburg,et al.  Hemodynamic changes in pregnancy. , 2000, Seminars in perinatology.

[41]  M. Fujita,et al.  Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.

[42]  B. M. Weiss,et al.  Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. , 2000, European heart journal.

[43]  S. Korones,et al.  Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report. , 2000, American journal of perinatology.

[44]  J. Markham,et al.  Pulmonary angiotensin-converting enzyme (ACE) binding and inhibition in humans. A positron emission tomography study. , 2000, American journal of respiratory and critical care medicine.

[45]  R. Simms,et al.  Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin). , 1999, Arthritis and rheumatism.

[46]  Y. Okano,et al.  Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension. , 1999, Journal of the American College of Cardiology.

[47]  M. Sklansky,et al.  Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. , 1999, The American journal of cardiology.

[48]  K. Kerr,et al.  Long-term outcome after pulmonary thromboendarterectomy. , 1999, American journal of respiratory and critical care medicine.

[49]  D. Badesch,et al.  Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.

[50]  V. Peinado,et al.  Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[51]  W. Auger,et al.  Outcome after pulmonary thromboendarterectomy. , 1999, Seminars in thoracic and cardiovascular surgery.

[52]  S. Hamada,et al.  Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[53]  M. Humbert,et al.  Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin). , 1998, Chest.

[54]  O. Hess,et al.  Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. , 1998, Journal of the American College of Cardiology.

[55]  L. Rubin,et al.  Primary pulmonary hypertension. , 1997, The New England journal of medicine.

[56]  M. Humbert,et al.  Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.

[57]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report--1998. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[58]  J. Scharf,et al.  Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report. , 1998, Journal of perinatal medicine.

[59]  F. Harrell,et al.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). , 1997, American heart journal.

[60]  S. Hodge,et al.  Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32. , 1997, Circulation.

[61]  N. Voelkel,et al.  Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. , 1997, Human pathology.

[62]  R. Speich,et al.  HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. , 1997, American journal of respiratory and critical care medicine.

[63]  N. D. Arnold,et al.  Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32 , 1997, Nature Genetics.

[64]  A. Denjean,et al.  Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension , 1996 .

[65]  M. Tischler,et al.  Prevalence of pulmonary hypertension in limited and diffuse scleroderma. , 1996, Chest.

[66]  J Benichou,et al.  Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.

[67]  W. Auger,et al.  Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. , 1996, Chest.

[68]  B. Groves,et al.  Pulmonary hypertension in chronic liver disease. , 1996, Clinics in chest medicine.

[69]  B. Groves,et al.  A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.

[70]  T. Ogihara,et al.  Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells. , 1995, Biochemical and biophysical research communications.

[71]  T. Albertson,et al.  Stimulant-induced pulmonary toxicity. , 1995, Chest.

[72]  A. Torbicki,et al.  More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. , 1995, The European respiratory journal.

[73]  M. Eisenberg,et al.  Pulmonary artery hypertension in chronic intravenous cocaine users. , 1995, American heart journal.

[74]  B. Dupas,et al.  Angiomagnetic resonance imaging of iliofemorocaval venous thrombosis , 1995, The Lancet.

[75]  G. Snell,et al.  Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.

[76]  A. Denjean,et al.  Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. , 1995, American journal of respiratory and critical care medicine.

[77]  E. Wouters,et al.  The International Primary Pulmonary Hypertension Study (IPPHS). , 1994, Chest.

[78]  G. Pietra.  Histopathology of primary pulmonary hypertension. , 1994, Chest.

[79]  S. Rich,et al.  Successful management of labor and delivery in primary pulmonary hypertension. , 1993, The American journal of cardiology.

[80]  V. Dzau.  The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. , 1993, Current opinion in nephrology and hypertension.

[81]  K. Badr,et al.  Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. , 1992, The New England journal of medicine.

[82]  B. Groves,et al.  An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. , 1992, The New England journal of medicine.

[83]  S. Rich,et al.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.

[84]  H. Palevsky,et al.  Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. , 1992, The American review of respiratory disease.

[85]  R. Speich,et al.  Primary pulmonary hypertension in HIV infection. , 1991, Chest.

[86]  S. Goldhaber.  Thrombolysis for pulmonary embolism. , 1991, Progress in cardiovascular diseases.

[87]  T. Evans,et al.  Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. , 1991, Chest.

[88]  P. Keast,et al.  Pulmonary Hypertension and Pregnancy – A Lethal Combination , 1990, Anaesthesia and intensive care.

[89]  B. Groves,et al.  Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. , 1989, Circulation.

[90]  K. Moser,et al.  Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. , 1988, Chest.

[91]  S. Factor,et al.  Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome. , 1987, Human pathology.

[92]  E H Bergofsky,et al.  Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.

[93]  D J Hagler,et al.  Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. , 1987, Journal of the American College of Cardiology.

[94]  T. Medsger,et al.  Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. , 1986, Arthritis and rheumatism.

[95]  J. Seward,et al.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. , 1985, Journal of the American College of Cardiology.

[96]  A. Van Tosh,et al.  Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.

[97]  E. Weitzenblum,et al.  Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1985, The American review of respiratory disease.

[98]  E. Greiser.  [Epidemiologic studies on the relation between use of appetite depressants and primary vascular pulmonary hypertension]. , 1973, Der Internist.

[99]  D. Nw.  Maternal death due to primary pulmonary hypertension. , 1972 .

[100]  L. Dunn,et al.  PRIMARY PULMONARY HYPERTENSION IN PREGNANCY. , 1964, Obstetrical & gynecological survey.